Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans

人类SARS-CoV-2 mRNA突破性感染后,记忆B细胞对Omicron亚型的反应

阅读:7
作者:Zijun Wang # ,Pengcheng Zhou # ,Frauke Muecksch # ,Alice Cho # ,Tarek Ben Tanfous ,Marie Canis ,Leander Witte ,Brianna Johnson ,Raphael Raspe ,Fabian Schmidt ,Eva Bednarski ,Justin Da Silva ,Victor Ramos ,Shuai Zong ,Martina Turroja ,Katrina G Millard ,Kai-Hui Yao ,Irina Shimeliovich ,Juan Dizon ,Anna Kaczynska ,Mila Jankovic ,Anna Gazumyan ,Thiago Y Oliveira ,Marina Caskey ,Christian Gaebler ,Paul D Bieniasz ,Theodora Hatziioannou ,Michel C Nussenzweig

Abstract

Individuals who receive a third mRNA vaccine dose show enhanced protection against severe COVID-19, but little is known about the impact of breakthrough infections on memory responses. Here, we examine the memory antibodies that develop after a third or fourth antigenic exposure by Delta or Omicron BA.1 infection, respectively. A third exposure to antigen by Delta breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a third mRNA vaccine dose. A fourth antigenic exposure with Omicron BA.1 infection increased variant-specific plasma antibody and memory B cell responses. However, the fourth exposure did not increase the overall frequency of memory B cells or their general potency or breadth compared to a third mRNA vaccine dose. In conclusion, a third antigenic exposure by Delta infection elicits strain-specific memory responses and increases in the overall potency and breadth of the memory B cells. In contrast, the effects of a fourth antigenic exposure with Omicron BA.1 are limited to increased strain-specific memory with little effect on the potency or breadth of memory B cell antibodies. The results suggest that the effect of strain-specific boosting on memory B cell compartment may be limited.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。